Psycheceutial Biosciences (BWVI) Listed on WeFunder!

Psycheceutical’s Psychedelic Experience, a Safer More Viable Choice in Getting Treated. Imagine the benefits of psychedelics, without hallucinating!

Zappy Zapolin Hopes To Put Ibogaine Front And Center For Addiction

“The only legitimate addiction interrupter capable of breaking a heroin, meth, opiate, or alcohol addiction in a single 12-hour session.”
Zappy Zapolin, Chad Harman, Kevin Harrington, Psychedelic Stock Review

Psycheceutical’s (BWVI) Delivery Tech is Grabbing Attention. Will Pharma Listen?

A startup’s psychedelic delivery tech is grabbing attention. Will pharma listen? PharmaVoice Psycheceutical is developing a back-of-the-neck topical treatment...

COMPASS Pathways (CMPS) Announces Up to $285 Million Private Placement

Transaction led by healthcare specialist investors, TCGX and Aisling Capital $125 million financing upfront with up to...

Billionaire, Point 72’s Steve Cohen, Continues to Support Psychedelic Research.

Cohen Psychedelic Research & Health Initiative Cohen Foundation Awards $5 Million for MDMA Therapy Approval Millions...

Psycheceutical’s (BWVI) NeuroDirect™ Ketamine can Help Alleviate Headaches and Migraines Within Minutes, With no...

Photo MAPS Founder Rick Doblin visits Psycheceutical's Chief Visionary Officer Mike 'Zappy' Zapolin, CEO Chad Harman at the company's lab and tests...

Psycheceutical Bioscience (BWVI) Secures Funding for Clinical Trials

Psycheceutical Secures Funding for Clinical Trials of NeuroDirect™ Ketamine Topical to Treat PTSD. Company raises $1.3M USD convertible note...

Psycheceutical Bioscience, Inc. Announces Observational Research Results for NeuroDirect™ Ketamine Topical Cream in Treating...

A pre-clinical observational study published in Drug Development & Delivery found that more than 80% of patients experienced relief within minutes of...

Video: New Topical Drug Delivery System, NeuroDirect™

Must Watch Video. Topical Application to Improve Delivery of FDA-Approved Drugs. https://youtu.be/2CGT7P9QEvo Can...

Topical PTSD Drug Poised for Human Trials.

In a press release issued on February 15, Psycheceutical Bioscience (BWVI), in partnership with iNGENū, a contract research organization in the cannabinoid...

Latest article

Post Reverse Split, Tharimmune (THAR) Announces Positive Phase I Results.

This is a story of 're-purposed' FDA approved drug, from drug overdose, to a solution for unrelenting itching. If approved, it can...

Trump’s (DJT) up 48% Today

LIVE QUOTE Our only thought is it would be a great idea, to give...

Altamira Thera (CYTO) Explodes 144% Higher Post Reverse Split, With 50 Million Shares Trading...

Taking advantage of post reverse-split investor pessimism, is a VALID investing technique. Altamira is developing and supplying peptide-based...